Prognostic Value of Mitral Annular Calcification in Liver Transplant Patients: Implication in Posttransplant Outcomes

Hwa-Young Jang1, Sang-Bin Han, Jun-Hyeop Jeong

  • 1Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Transplantation
|March 19, 2024
PubMed

Insights

Mitral annular calcification (MAC) in liver transplant (LT) candidates is linked to higher short-term cardiac events and worse long-term survival, particularly in women. Early identification and management of MAC are vital for improving LT outcomes.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Medicine

Background:

  • Metabolic diseases and aging increase the prevalence of mitral annular calcification (MAC) in liver transplant (LT) candidates.
  • Cardiovascular disease is a leading cause of mortality in LT recipients, yet the impact of MAC remains understudied.
  • This study examines MAC prevalence, associated factors, and its effect on LT outcomes.

Purpose of the Study:

  • To investigate the prevalence of mitral annular calcification (MAC) in liver transplant (LT) candidates.
  • To identify factors associated with MAC in this population.
  • To determine the impact of pre-LT MAC on major adverse cardiac events (MACE) and long-term survival after LT.

Main Methods:

  • A cohort of 4148 LT patients undergoing pretransplant echocardiography from 2008-2019 was analyzed.
  • Multivariate logistic analysis and Shapley additive explanation (SHAP) scores were used to identify significant factors related to MAC.
  • Primary outcome was 30-day MACE; secondary outcome was 5-year cumulative all-cause mortality.

Main Results:

  • MAC was present in 3.0% of patients, associated with age, alcoholic liver disease, chronic kidney disease, hyperuricemia, hypertension, and coronary artery disease.
  • Patients with MAC had significantly higher 30-day MACE rates (adjusted HR 1.67) and poorer cumulative survival (adjusted HR 1.47).
  • Women with MAC showed a markedly poorer long-term survival probability compared to men without MAC (>10 years post-LT).

Conclusions:

  • Pre-LT MAC is associated with increased short-term MACE and reduced long-term survival.
  • Women with MAC represent a particularly high-risk group for adverse outcomes post-LT.
  • Identifying and managing MAC and its risk factors are critical for enhancing post-LT patient survival.
Abstract

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...